NPPB and Left atrial enlargement: The ARCADIA trial is currently investigating whether a subgroup of ESUS-patients exhibiting features of atrial cardiopathy as determined by elevated NT-proBNP, prolonged PTFV1 or left atrial enlargement might benefit from oral anticoagulation rather than platelet aggregation inhibition34.